Hematologic Malignancies

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumors, Lymphoma, Multiple Myeloma Trial in Nashville, Houston (AZD0466)

Terminated
  • Advanced Solid Tumors
  • +3 more
  • Nashville, Tennessee
  • +1 more
Apr 22, 2022

Hematologic Malignancies Trial in United States (IPI-145 (duvelisib))

Terminated
  • Hematologic Malignancies
  • IPI-145 (duvelisib)
  • New York, New York
  • +3 more
Mar 15, 2021

Advanced Solid Malignancies, Hematologic Malignancies Trial in Fort Myers, Oklahoma City, Nashville (MLN0128, paclitaxel,

Completed
  • Advanced Solid Malignancies
  • Hematologic Malignancies
  • Fort Myers, Florida
  • +2 more
Jun 28, 2019

Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)

Terminated
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +55 more
May 28, 2019

Tumors, Hematologic Malignancies Trial in Worldwide (Atezolizumab)

Completed
  • Tumors
  • Hematologic Malignancies
  • Scottsdale, Arizona
  • +20 more
Dec 10, 2018

Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)

Completed
  • Chronic Myelogenous Leukemia
  • Hematologic Malignancies
  • San Francisco, California
  • +4 more
May 15, 2018